Previous Close | 0.3000 |
Open | 0.3000 |
Bid | 0.0000 |
Ask | 0.3000 |
Strike | 22.50 |
Expire Date | 2024-06-21 |
Day's Range | 0.3000 - 0.3000 |
Contract Range | N/A |
Volume | |
Open Interest | 55 |
Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, has signed five virtual power purchase agreements (vPPAs) with wind and solar energy project developers in Germany and the U.S. The projects are expected to feed around 580 gigawatt hours of renewable energy into the grid, which equals up to 46 percent of FME's most recently reported global consumption. The company is thus taking an important step towards its goal of reducing emiss
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...